SLC1A7

Chr 1

solute carrier family 1 member 7

Also known as: AAAT, EAAT5

SLC1A7 encodes a sodium-dependent glutamate transporter that mediates high-affinity uptake of glutamate and aspartate, and also functions as an inhibitory glutamate-gated chloride channel at rod bipolar cell terminals in the retina. Mutations cause autosomal recessive episodic ataxia with retinal dysfunction, affecting both neurological and visual systems. The gene shows minimal constraint against loss-of-function variants (very low pLI score), consistent with recessive inheritance where heterozygous carriers are typically unaffected.

OMIMResearchSummary from RefSeq, UniProt
MultiplemechanismLOEUF 1.31
Clinical SummarySLC1A7
Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
9 unique Pathogenic / Likely Pathogenic· 115 VUS of 141 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
1.31LOEUF
pLI 0.000
Z-score 0.52
OE 0.87 (0.601.31)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint
0.07Z-score
OE missense 0.99 (0.911.08)
358 obs / 362.0 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios
LoF OE0.87 (0.601.31)
00.351.4
Missense OE0.99 (0.911.08)
00.61.4
Synonymous OE1.02
01.21.6
LoF obs/exp: 17 / 19.5Missense obs/exp: 358 / 362.0Syn Z: -0.24
DN
0.76top 25%
GOF
0.80top 10%
LOF
0.2678th %ile

This gene has evidence for multiple mechanisms of pathogenicity (gain-of-function and dominant-negative). Both the Badonyi & Marsh prediction and the broader genomic evidence point to gain-of-function as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

GOFprediction above median
DNprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

141 submitted variants in ClinVar

Classification Summary

Pathogenic6
Likely Pathogenic3
VUS115
Likely Benign8
Benign1
6
Pathogenic
3
Likely Pathogenic
115
VUS
8
Likely Benign
1
Benign

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
0
6
0
6
Likely Pathogenic
0
0
3
0
3
VUS
0
112
3
0
115
Likely Benign
0
5
1
2
8
Benign
0
0
0
1
1
Total0117133133

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

SLC1A7 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

3D Protein StructureAlphaFold

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →
Recent Gene-Specific Literature
Gene in title · MEDLINE · newest first
Europe PMC

No open access results found